422 related articles for article (PubMed ID: 35611169)
1. Identification of vaccine targets & design of vaccine against SARS-CoV-2 coronavirus using computational and deep learning-based approaches.
Abbasi BA; Saraf D; Sharma T; Sinha R; Singh S; Sood S; Gupta P; Gupta A; Mishra K; Kumari P; Rawal K
PeerJ; 2022; 10():e13380. PubMed ID: 35611169
[TBL] [Abstract][Full Text] [Related]
2. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
[TBL] [Abstract][Full Text] [Related]
3. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
Yang Z; Bogdan P; Nazarian S
Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
[TBL] [Abstract][Full Text] [Related]
4. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.
Jahangirian E; Jamal GA; Nouroozi M; Mohammadpour A
Immunogenetics; 2021 Dec; 73(6):459-477. PubMed ID: 34542663
[TBL] [Abstract][Full Text] [Related]
5. Reverse vaccinology-based prediction of a multi-epitope SARS-CoV-2 vaccine and its tailoring to new coronavirus variants.
Ezzemani W; Kettani A; Sappati S; Kondaka K; El Ossmani H; Tsukiyama-Kohara K; Altawalah H; Saile R; Kohara M; Benjelloun S; Ezzikouri S
J Biomol Struct Dyn; 2023 Jul; 41(11):4917-4938. PubMed ID: 35549819
[TBL] [Abstract][Full Text] [Related]
6. A conserved subunit vaccine designed against SARS-CoV-2 variants showed evidence in neutralizing the virus.
Kibria KMK; Faruque MO; Islam MSB; Ullah H; Mahmud S; Miah M; Saleh AA
Appl Microbiol Biotechnol; 2022 Jun; 106(11):4091-4114. PubMed ID: 35612630
[TBL] [Abstract][Full Text] [Related]
7. Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant.
Khan K; Khan SA; Jalal K; Ul-Haq Z; Uddin R
Virology; 2022 Jul; 572():28-43. PubMed ID: 35576833
[TBL] [Abstract][Full Text] [Related]
8. Coevolution based immunoinformatics approach considering variability of epitopes to combat different strains: A case study using spike protein of SARS-CoV-2.
Mishra SK; Priya P; Rai GP; Haque R; Shanker A
Comput Biol Med; 2023 Sep; 163():107233. PubMed ID: 37422941
[TBL] [Abstract][Full Text] [Related]
9. Genome based evolutionary lineage of SARS-CoV-2 towards the development of novel chimeric vaccine.
Akhand MRN; Azim KF; Hoque SF; Moli MA; Joy BD; Akter H; Afif IK; Ahmed N; Hasan M
Infect Genet Evol; 2020 Nov; 85():104517. PubMed ID: 32882432
[TBL] [Abstract][Full Text] [Related]
10. Exploiting reverse vaccinology approach for the design of a multiepitope subunit vaccine against the major SARS-CoV-2 variants.
Campos DMO; Silva MKD; Barbosa ED; Leow CY; Fulco UL; Oliveira JIN
Comput Biol Chem; 2022 Dec; 101():107754. PubMed ID: 36037724
[TBL] [Abstract][Full Text] [Related]
11. In silico SARS-CoV-2 vaccine development for Omicron strain using reverse vaccinology.
Li V; Lee C; Yoo D; Cho S; Kim H
Genes Genomics; 2022 Aug; 44(8):937-944. PubMed ID: 35665465
[TBL] [Abstract][Full Text] [Related]
12. Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches.
Tahir Ul Qamar M; Rehman A; Tusleem K; Ashfaq UA; Qasim M; Zhu X; Fatima I; Shahid F; Chen LL
PLoS One; 2020; 15(12):e0244176. PubMed ID: 33351863
[TBL] [Abstract][Full Text] [Related]
13. Whole proteome screening and identification of potential epitopes of SARS-CoV-2 for vaccine design-an immunoinformatic, molecular docking and molecular dynamics simulation accelerated robust strategy.
Ezaj MMA; Junaid M; Akter Y; Nahrin A; Siddika A; Afrose SS; Nayeem SMA; Haque MS; Moni MA; Hosen SMZ
J Biomol Struct Dyn; 2022 Sep; 40(14):6477-6502. PubMed ID: 33586620
[TBL] [Abstract][Full Text] [Related]
14. Designing of cytotoxic T lymphocyte-based multi-epitope vaccine against SARS-CoV2: a reverse vaccinology approach.
Vivekanandam R; Rajagopalan K; Jeevanandam M; Ganesan H; Jagannathan V; Selvan Christyraj JD; Kalimuthu K; Selvan Christyraj JRS; Mohan M
J Biomol Struct Dyn; 2022; 40(24):13711-13726. PubMed ID: 34696708
[TBL] [Abstract][Full Text] [Related]
15. Exploring SARS-COV-2 structural proteins to design a multi-epitope vaccine using immunoinformatics approach: An in silico study.
Sanami S; Alizadeh M; Nosrati M; Dehkordi KA; Azadegan-Dehkordi F; Tahmasebian S; Nosrati H; Arjmand MH; Ghasemi-Dehnoo M; Rafiei A; Bagheri N
Comput Biol Med; 2021 Jun; 133():104390. PubMed ID: 33895459
[TBL] [Abstract][Full Text] [Related]
16. Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach.
Sanami S; Zandi M; Pourhossein B; Mobini GR; Safaei M; Abed A; Arvejeh PM; Chermahini FA; Alizadeh M
Int J Biol Macromol; 2020 Dec; 164():871-883. PubMed ID: 32682041
[TBL] [Abstract][Full Text] [Related]
17.
Pal A; Pyne N; Paul S
Curr Drug Discov Technol; 2023; 20(1):e090922208713. PubMed ID: 36093818
[TBL] [Abstract][Full Text] [Related]
18. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y
Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882
[TBL] [Abstract][Full Text] [Related]
19. MERS virus spike protein HTL-epitopes selection and multi-epitope vaccine design using computational biology.
Joshi A; Akhtar N; Sharma NR; Kaushik V; Borkotoky S
J Biomol Struct Dyn; 2023; 41(22):12464-12479. PubMed ID: 36935104
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential vaccine targets for elicitation of host immune cells against SARS-CoV-2 by reverse vaccinology approach.
Yasmin S; Ansari MY; Pandey K; Dikhit MR
Int J Biol Macromol; 2024 Apr; 265(Pt 2):130754. PubMed ID: 38508555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
